ZYVOX, generically known as linezolid, is an antibiotic medication used to treat various bacterial infections, including pneumonia, skin infections, and infections that are resistant to other antibiotics. As a member of the oxazolidinone class, ZYVOX works by inhibiting the protein synthesis of bacteria, effectively stopping their growth and spread. It is notable for its effectiveness against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), making it a valuable option in the treatment of drug-resistant infections. ZYVOX can be administered orally or intravenously, offering flexibility in treatment approaches. However, like all antibiotics, its use must be carefully managed to avoid the development of drug-resistant bacteria.